But now in the coming months we’ll see the first large-scale uses of a vaccine that also has a potentially huge role to play in reducing AMR. This is a vaccine that protects against typhoid, which is one of the biggest drivers of drug resistance.
TCV is more effective than existing vaccines and offers longer protection, but it can also be given to younger children thereby covering a larger proportion of the population. In places like Karachi, where antibiotic resistance is increasing by 30 per cent annually and may reach a point where all cases will be resistant to multiple drugs as early as next year, having greater vaccination coverage to prevent the disease will go a long way.
The vaccine has already been used locally to reduce the spread of the outbreak, and plans are in place to introduce this vaccination nationally later this year.